CPH 0.00% 0.9¢ creso pharma limited

All looks good for the road ahead .......... (from the CEO's...

  1. 101 Posts.
    lightbulb Created with Sketch. 40
    All looks good for the road ahead .......... (from the CEO's announcement 28-2-2019)

    Quote:- Total product sales are on the right track, increasing by over 500% from $91,609 in 2017 to $558,382 in 2018. New product pipeline To complement and expand our current portfolio, Creso has developed several new products. Additional nutraceutical products have been developed, including; • “cannaQIX®nite” to aid sleep; • “cannaPEAL®” to introduce certain markets to the benefits of hemp seed oil-based products; and • “cannaDOL®” to provide relief to athletes in the form of a topical application. The pipeline extends well beyond this, and every product is designed with a specific purpose and efficacy.

    Global expansion The primary focus of Creso’s strategy is to build a global brand. Creso started by introducing its hemp CBD formulas to markets that readily accepted the commercialisation of CBD products. Many of these markets are still defining their position on CBD, hemp, medical or recreational cannabis. Creso will also introduce products with hemp seed oil but without CBD into emerging markets like Indonesia and Thailand. All Creso products focus on effectiveness and quality, through formulation and understanding how the plant ingredients are delivered to the body. As cannabis markets evolve, product design can seamlessly introduce THC as an ingredient, thereby expanding potential patient and consumer base. In anticipation of this, Creso has invested in cannabis cultivation and the benefits are already being reaped, with a license to cultivate being granted by Health Canada this month to our “Mernova Medical” state-of-the-art, GMP ready, indoor facility in Windsor, Nova Scotia. This gives Mernova Medical the ability to immediately plant crops and importantly, to already sell the first crops planted B2B. With a supply agreement already signed with TerrAscend Canada, a Licensed Producer (LP), revenue for 2019 is now assured. In 2019, the Nova Scotia facility will build out its “edible cannabis” processing plant. It is also anticipated that our Ritual Green Brand of flower will be sold in the Nova Scotia Liquor Corporation’s retail distribution channels. -:End Quote
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.